Bupropion-neuraxpharm 150 mg modified-release tablets

Bupropion-neuraxpharm is a generic medication containing bupropion hydrochloride, used primarily for the treatment of major depressive episodes and sometimes as an aid for smoking cessation. The brand 'neuraxpharm' is a well-established name in the European pharmaceutical market, specializing in central nervous system (CNS) disorders. Established in Germany, the company focuses on providing affordable generic alternatives to brand-name psychiatric and neurological medications.

Today, Neuraxpharm is a significant player in the European pharmaceutical scene. The brand originated in Langenfeld, Germany, and continues to maintain a strong manufacturing and distribution presence there. Following various corporate acquisitions to expand its footprint across Europe, the company is currently owned by the global investment firm Permira. The headquarters for the Neuraxpharm Group are located in Barcelona, Spain and Düsseldorf, Germany, reflecting its broad European reach.